Mucorales PCR Testing in Respiratory and Biopsy Samples From Immunocompromised Patients With Invasive Pulmonary Aspergillosis and Other Mold Infections: Results From a Multicenter ECMM Study
Open Forum Infectious Diseases · 26.12.2025 · 13 (1)
DOI: 10.1093/ofid/ofaf801 ↗Kurz gefasst
Fachartikel in der Zeitschrift Open Forum Infectious Diseases, online erschienen am 30.12.2025. Verfasst von Sarah Sedik und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Division of Infectious Diseases, Medical University of Graz, Translational Mycology Research Center, Excellence Cent…. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Pfizer, Sofie Vanmechelen and Kurt Beuselinck.
Abstract (Originalsprache)
Background
Mucormycosis is a severe fungal infection that is challenging to diagnose as traditional methods lack sensitivity and serological testing is unavailable. This study aimed to evaluate the MucorGenius® PCR assay on respiratory and biopsy samples from high-risk patients with probable/proven invasive pulmonary aspergillosis (IPA), mucormycosis, or possible invasive mold infections (IMIs).
Methods
This multicenter cohort study was conducted across 4 sites in Austria, Belgium and the UK. A total of 132 respiratory and biopsy samples from 114 patients with IMI diagnosed in clinical routine (10 proven IPA, 13 proven mucormycosis, 62 probable IPA, 5 probable mucormycosis, and 35 possible IMI according to EORTC/MSGERC 2020 and FUNDICU criteria; 11 IPA/mucormycosis coinfections) were analyzed using the MucorGenius® PCR assay in ISO-certified laboratories. Results were compared with standard fungal diagnostics.
Results
Mucorales DNA was detected in 37/132 samples (28%) including 29 BAL fluids, 1 bronchial aspirate, 1 endotracheal aspirate, and 6 biopsies from 37 patients. Sensitivity was 94.4% (17/18) for detecting probable/proven mucormycosis (including 11 cases routinely diagnosed with IPA/mucormycosis coinfection). Among 72 patients with probable/proven IPA, 21 (29.2%) tested positive for Mucorales DNA, including 11 missed by routine diagnostics. Mucorales DNA was also detected in 9/35 (25.7%) of patients with possible IMI.
Conclusions
MucorGenius® PCR showed high sensitivity for detecting Mucorales and may support improved diagnosis of probable mucormycosis when included as a mycological criterion. It appears particularly valuable for identifying Aspergillus-Mucorales coinfections and detecting mucormycosis in patients with host factors, clinical or radiological evidence of IMI when routine diagnostics are negative.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Division of Infectious Diseases, Medical University of Graz, Translational Mycology Research Center, Excellence Centre for Medical Mycology (ECMM), Graz, Austria.
- Department of Microbiology, Immunology and Transplantation KU Leuven, Leuven, Belgium.
- Department of Laboratory Medicine, National Reference Center for Mycosis and Excellence Centre for Medical Mycology (ECMM) UZ Leuven, Leuven, Belgium.
- Public Health Wales Mycology Reference Laboratory and Cardiff University Centre for Trials Research, University Hospital of Wales, Cardiff, UK.
- Infection Sciences, King's College Hospital, London, UK.
- Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, The Netherlands.
ORCID-Profile: Sarah Sedik, Robina Aerts, Katrien Lagrou, Yuri Vanbiervliet, Jochem B Buil, Juergen Prattes, Martin Hoenigl
Förderung
- Pfizer
- Sofie Vanmechelen and Kurt Beuselinck
Zitieren
APA
Sedik, S., Aerts, R., Lagrou, K., Vanbiervliet, Y., Maertens, J. A., White, P. L., Posso, R. B., Schelenz, S., Abdolrasouli, A., Buil, J. B., Dichtl, K., Kessler, H. H., Prattes, J., & Hoenigl, M. (2025). Mucorales PCR Testing in Respiratory and Biopsy Samples From Immunocompromised Patients With Invasive Pulmonary Aspergillosis and Other Mold Infections: Results From a Multicenter ECMM Study. Open Forum Infectious Diseases, 13(1). https://doi.org/10.1093/ofid/ofaf801
Vancouver
Sedik S, Aerts R, Lagrou K, Vanbiervliet Y, Maertens JA, White PL, et al. Mucorales PCR Testing in Respiratory and Biopsy Samples From Immunocompromised Patients With Invasive Pulmonary Aspergillosis and Other Mold Infections: Results From a Multicenter ECMM Study. Open Forum Infectious Diseases. 2025;13(1). doi:10.1093/ofid/ofaf801
BibTeX
@article{Sedik2025,
author = {Sedik, Sarah and Aerts, Robina and Lagrou, Katrien and Vanbiervliet, Yuri and Maertens, Johan A and White, P Lewis and Posso, Raquel B and Schelenz, Silke and Abdolrasouli, Alireza and Buil, Jochem B and Dichtl, Karl and Kessler, Harald H and Prattes, Juergen and Hoenigl, Martin},
title = {Mucorales PCR Testing in Respiratory and Biopsy Samples From Immunocompromised Patients With Invasive Pulmonary Aspergillosis and Other Mold Infections: Results From a Multicenter ECMM Study},
journal = {Open Forum Infectious Diseases},
year = {2025},
volume = {13},
number = {1},
doi = {10.1093/ofid/ofaf801}
}
EUVIMED